Today’s issue of WorkCompRecap features the TDI-DWC’s recent announcement that it is accepting public comment on rules to address compounded drugs in the state’s workers’ compensation system.
The Proposed amendments state rules will exclude all prescription drugs created through compounding from the closed formulary, and additional amendments will require preauthorization of compounded drugs for claims subject to and not subject to certified networks. The proposed rule change does not prohibit the use of compounded drugs for injured employees when medically necessary; however, it does require that the medical necessity be determined prior to their dispensing. The DWC noted that the cost of compounded drugs doubled from 2010-2014, and the average cost per prescription had risen to $829 in 2016, a concerning development given that compounded drugs aren’t recommended as first line medications in treatment guidelines for injured employees.
Find out more by clicking here!